Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
| 17 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 124793 |
| 201 | 2 | IMMUNOTHERAPY//DENDRITIC CELLS//MYELOID DERIVED SUPPRESSOR CELLS | 20719 |
| 27441 | 1 | RAS DERIVED PEPTIDES//P53 PEPTIDES//RAS PEPTIDES | 249 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | RAS DERIVED PEPTIDES | authKW | 506294 | 2% | 100% | 4 |
| 2 | P53 PEPTIDES | authKW | 379720 | 1% | 100% | 3 |
| 3 | RAS PEPTIDES | authKW | 337526 | 2% | 67% | 4 |
| 4 | MUTANT P21 RAS | authKW | 284789 | 1% | 75% | 3 |
| 5 | MUTATED RAS P21 | authKW | 253147 | 1% | 100% | 2 |
| 6 | P53 EPITOPES | authKW | 253147 | 1% | 100% | 2 |
| 7 | PEPTIDE MAJOR HISTOCOMPATIBILITY COMPLEX AFFINITY | authKW | 253147 | 1% | 100% | 2 |
| 8 | ANTI SELF | authKW | 126573 | 0% | 100% | 1 |
| 9 | ASSOCIE 9 COMITE PARIS LIGUE CONTRE CANC | address | 126573 | 0% | 100% | 1 |
| 10 | BCL2 EPITOPE | authKW | 126573 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Immunology | 2343 | 46% | 0% | 115 |
| 2 | Oncology | 2178 | 49% | 0% | 121 |
| 3 | Medicine, Research & Experimental | 432 | 16% | 0% | 41 |
| 4 | Industrial Relations & Labor | 133 | 2% | 0% | 5 |
| 5 | Biotechnology & Applied Microbiology | 34 | 6% | 0% | 16 |
| 6 | Genetics & Heredity | 16 | 5% | 0% | 12 |
| 7 | Cell Biology | 6 | 5% | 0% | 12 |
| 8 | Hematology | 4 | 2% | 0% | 5 |
| 9 | Dermatology | 2 | 1% | 0% | 3 |
| 10 | Transplantation | 1 | 1% | 0% | 2 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ASSOCIE 9 COMITE PARIS LIGUE CONTRE CANC | 126573 | 0% | 100% | 1 |
| 2 | CANC ETIOL OUTCOMES | 126573 | 0% | 100% | 1 |
| 3 | CELL CELL THER IES CORE IL | 126573 | 0% | 100% | 1 |
| 4 | CHAIRE BOMNBARDIER | 126573 | 0% | 100% | 1 |
| 5 | COMITE PARIS LIGUE CONTRE CANC ASSOCIE 9 | 126573 | 0% | 100% | 1 |
| 6 | DIAGNOST MOL PATHOL SERV | 126573 | 0% | 100% | 1 |
| 7 | HEMATOL ONCOL MEDPENN STATE HERSHEY CAN | 126573 | 0% | 100% | 1 |
| 8 | IMMUNOL IMM15 | 126573 | 0% | 100% | 1 |
| 9 | IMPCL | 126573 | 0% | 100% | 1 |
| 10 | LUACR | 126573 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 8233 | 7% | 0% | 17 |
| 2 | JOURNAL OF IMMUNOTHERAPY | 2661 | 2% | 0% | 6 |
| 3 | CURRENT MOLECULAR PHARMACOLOGY | 2258 | 0% | 2% | 1 |
| 4 | RELATIONS INDUSTRIELLES-INDUSTRIAL RELATIONS | 2128 | 2% | 0% | 4 |
| 5 | CLINICAL CANCER RESEARCH | 2105 | 6% | 0% | 16 |
| 6 | INTERNATIONAL JOURNAL OF CANCER | 1986 | 7% | 0% | 18 |
| 7 | CANCER GENE THERAPY | 1610 | 2% | 0% | 5 |
| 8 | EUROPEAN JOURNAL OF IMMUNOLOGY | 1602 | 5% | 0% | 13 |
| 9 | PORTLAND PRESS PROCEEDINGS | 1542 | 0% | 1% | 1 |
| 10 | CELLULAR IMMUNOLOGY | 1021 | 3% | 0% | 8 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | RAS DERIVED PEPTIDES | 506294 | 2% | 100% | 4 | Search RAS+DERIVED+PEPTIDES | Search RAS+DERIVED+PEPTIDES |
| 2 | P53 PEPTIDES | 379720 | 1% | 100% | 3 | Search P53+PEPTIDES | Search P53+PEPTIDES |
| 3 | RAS PEPTIDES | 337526 | 2% | 67% | 4 | Search RAS+PEPTIDES | Search RAS+PEPTIDES |
| 4 | MUTANT P21 RAS | 284789 | 1% | 75% | 3 | Search MUTANT+P21+RAS | Search MUTANT+P21+RAS |
| 5 | MUTATED RAS P21 | 253147 | 1% | 100% | 2 | Search MUTATED+RAS+P21 | Search MUTATED+RAS+P21 |
| 6 | P53 EPITOPES | 253147 | 1% | 100% | 2 | Search P53+EPITOPES | Search P53+EPITOPES |
| 7 | PEPTIDE MAJOR HISTOCOMPATIBILITY COMPLEX AFFINITY | 253147 | 1% | 100% | 2 | Search PEPTIDE+MAJOR+HISTOCOMPATIBILITY+COMPLEX+AFFINITY | Search PEPTIDE+MAJOR+HISTOCOMPATIBILITY+COMPLEX+AFFINITY |
| 8 | ANTI SELF | 126573 | 0% | 100% | 1 | Search ANTI+SELF | Search ANTI+SELF |
| 9 | BCL2 EPITOPE | 126573 | 0% | 100% | 1 | Search BCL2+EPITOPE | Search BCL2+EPITOPE |
| 10 | CANCER PRONE MICE | 126573 | 0% | 100% | 1 | Search CANCER+PRONE+MICE | Search CANCER+PRONE+MICE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |